11
Participants
Start Date
January 18, 2023
Primary Completion Date
December 30, 2024
Study Completion Date
December 30, 2024
Ontamalimab
Ontamalimab SC injection.
VCU Dept of Internal Medicine, Division of GI, Hepatology & Nutrition, Richmond
Lucas Research, Inc, Morehead City
Covenant Metabolic Specialist LLC, Fort Myers
Covenant Metabolic Specialist LLC, Sarasota
Tandem Clinical Research GI, LLC, Marrero
The Liver Institute at Methodist Dallas Medical Center, Dallas
Houston Research Institute, Houston
Texas Liver Institute, San Antonio
Pinnacle Clinical Research LLC, San Antonio
Arizona Liver Health, Chandler
Adobe Clinical Research, LLC, Tucson
California Liver Research Institute, Pasadena
University of California, San Diego, NAFLD Research Center, La Jolla
Southern California Research Center, Coronado
Inland Empire Clinical Trials, LLC, Rialto
Lead Sponsor
Takeda
INDUSTRY